News | December 18, 2025
Godavari Biorefineries launches US biotech arm to advance novel cancer therapies
The move strengthens GBL’s clinical-stage presence in the United States
The move strengthens GBL’s clinical-stage presence in the United States
The collaboration to develop breakthrough myeloid cell engagers (MCEs) signals a bold push into a promising new frontier in cancer therapy
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system
The trial met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in progression-free survival
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
Takeda will pay Innovent US$1.2 billion upfront, including a US$100 million equity investment in Innovent
GV20 received an upfront payment and is eligible for additional milestone payments
Merus has licensed Halozyme’s proprietary ENHANZE technology to develop and commercialize subcutaneous formulations of petosemtamab
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
Subscribe To Our Newsletter & Stay Updated
